An introduction to the methods of cost-effectiveness analysis.
The comparative cost-effectiveness of interventions is a fundamental consideration of health technology assessment (HTA) in the UK.(1) The use of modelling to extrapolate benefits to patients and costs over a specified time period is a common technique in cost-effectiveness analyses. All modelling techniques, by their nature, are subject to different levels of uncertainty. Assessment and understanding of the level and impact of this uncertainty is a fundamental part of the decision-making process. In this article, we build on our previous article A guide to health economic evaluations and discuss different modelling approaches to cost-effectiveness analysis and the importance of uncertainty.(2)
D003362:Cost-Benefit Analysis / Q000379:methods; D003661:Decision Support Techniques; D003663:Decision Trees; D008390:Markov Chains; D018803:Models, Economic; D013673:Technology Assessment, Biomedical / Q000191:economics*; D035501:Uncertainty